These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20720406)

  • 1. Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis.
    Zhou C; Wu J; Torres L; Hicks JM; Bartkowiak T; Parker K; Lou YH
    Am J Nephrol; 2010; 32(4):324-31. PubMed ID: 20720406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin overproduction is associated with progression of glomerular fibrosis in a rat model of anti-glomerular basement membrane glomerulonephritis.
    Merszei J; Wu J; Torres L; Hicks JM; Bartkowiak T; Tan F; Lou YH
    Am J Nephrol; 2010; 32(3):262-271. PubMed ID: 20714131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating Glomerular Inflammation from Fibrosis in a Bone Marrow Chimera for Rat Anti-Glomerular Basement Membrane Glomerulonephritis.
    Zhou C; Lou K; Tatum K; Funk J; Wu J; Bartkowiak T; Kagan D; Lou Y
    Am J Nephrol; 2015; 42(1):42-53. PubMed ID: 26337665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat.
    Yu XQ; Fan JM; Nikolic-Paterson DJ; Yang N; Mu W; Pichler R; Johnson RJ; Atkins RC; Lan HY
    Am J Pathol; 1999 Mar; 154(3):833-41. PubMed ID: 10079261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis.
    Lan HY; Yu XQ; Yang N; Nikolic-Paterson DJ; Mu W; Pichler R; Johnson RJ; Atkins RC
    Kidney Int; 1998 Jan; 53(1):136-45. PubMed ID: 9453010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
    Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats through anti-inflammatory effects.
    Tachibana S; Iyoda M; Matsumoto K; Wada Y; Suzuki T; Iseri K; Kanazawa N; Shibata T
    Nephrol Dial Transplant; 2019 May; 34(5):774-782. PubMed ID: 29982644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and cell cycle regulation in the fibrous progression of crescent formation in antiglomerular basement membrane nephritis of WKY rats.
    Fujigaki Y; Sun DF; Fujimoto T; Yonemura K; Morioka T; Yaoita E; Hishida A
    Virchows Arch; 2001 Jul; 439(1):35-45. PubMed ID: 11499838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous recovery from early glomerular inflammation is associated with resistance to anti-GBM glomerulonephritis: tolerance and autoimmune tissue injury.
    Robertson J; Wu J; Arends J; Zhou C; Adrogue HE; Chan JT; Lou Y
    J Autoimmun; 2008 Jun; 30(4):246-56. PubMed ID: 18054199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
    Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
    Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage metalloelastase as a major factor for glomerular injury in anti-glomerular basement membrane nephritis.
    Kaneko Y; Sakatsume M; Xie Y; Kuroda T; Igashima M; Narita I; Gejyo F
    J Immunol; 2003 Mar; 170(6):3377-85. PubMed ID: 12626598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
    Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
    Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased production of adrenomedullin in glomeruli from anti-glomerular basement membrane glomerulonephritis rats treated with methylprednisolone.
    Iwatsubo S; Fujimoto S; Matsumoto M; Sato Y; Hara S; Kitamura K; Eto T
    Nephron Exp Nephrol; 2006; 104(1):e41-7. PubMed ID: 16735801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.
    Takeda S; Takahashi M; Sado Y; Takeuchi K; Hakamata Y; Shimizu H; Kaneko T; Yamamoto H; Ito C; Ookawara S; Asano Y; Kusano E; Kobayashi E
    Nephrol Dial Transplant; 2004 Sep; 19(9):2228-36. PubMed ID: 15238626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical characterization of glomerular inflammatory cells and expression of adhesion molecules in anti-glomerular basement membrane (anti-GBM) glomerulonephritis induced in WKY rats with monoclonal anti-GBM antibodies of different subclasses.
    Kado T; Kohda T; Okada S; Hayashi A; Utsunomiya Y; Kanzaki S; Sado Y; Yamamoto T
    Pathol Int; 2006 Feb; 56(2):55-61. PubMed ID: 16445816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of global osteopontin and macrophage osteopontin in glomerular injury.
    Trostel J; Truong LD; Roncal-Jimenez C; Miyazaki M; Miyazaki-Anzai S; Kuwabara M; McMahan R; Andres-Hernando A; Sato Y; Jensen T; Lanaspa MA; Johnson RJ; Garcia GE
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F759-F768. PubMed ID: 29717936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
    El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
    Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-perforin antibody treatment ameliorates experimental crescentic glomerulonephritis in WKY rats.
    Fujinaka H; Yamamoto T; Feng L; Nameta M; Garcia G; Chen S; El-shemi AA; Ohshiro K; Katsuyama K; Yoshida Y; Yaoita E; Wilson CB
    Kidney Int; 2007 Oct; 72(7):823-30. PubMed ID: 17622272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.
    Ma FY; Flanc RS; Tesch GH; Bennett BL; Friedman GC; Nikolic-Paterson DJ
    Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of in vivo function of osteopontin in experimental anti-GBM nephritis.
    Bonvini JM; Schatzmann U; Beck-Schimmer B; Sun LK; Rittling SR; Denhardt DT; LE Hir M; Wüthrich RP
    J Am Soc Nephrol; 2000 Sep; 11(9):1647-1655. PubMed ID: 10966489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.